Overview

Effect of Quetiapine on Negative Symptoms and Cognition

Status:
Completed
Trial end date:
2003-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate the outcome on negative symptoms of schizophrenic patients during therapy with quetiapine or risperidone.
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Quetiapine Fumarate
Risperidone